A patient presents with new-onset joint pain and is discovered to have a cardiac condition.
Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.
Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.
Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.
A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.
While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.
Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"
Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.
Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.
Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.
Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.
Patients with heart failure rarely use evidence-based alternative treatments such as yoga or massage, to manage their comorbid chronic pain.
The FDA has approved CaroSpir, the first oral liquid formulation of spironolactone for hypertension and heart failure treatment.
Most pharmacotherapies appear not to have significant effect on all-cause or cardiovascular mortality in heart failure with preserved ejection fraction.
Researchers have used a gene-editing tool to repair the segment of DNA that causes hypertrophic cardiomyopathy.
N-terminal pro-B-type natriuretic peptide showed the strongest association with heart failure in patients with type 2 diabetes.
Greater left ventricle mass and left ventricle mass indexed to height were found in participants with a history of childhood asthma.
In patients with acute myocardial infarction without heart failure, beta-blockers did not reduce mortality risk at 1 year.
Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.
Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation
Patients with heart failure with reduced ejection fraction and iron deficiency do not benefit from iron supplementation.
Patients with acute heart failure who received intravenous morphine in the emergency department had higher mortality compared with patients who did not receive morphine.
Women with fewer menstrual cycles are at a higher risk for incident heart failure.
The Cardiology Advisor Articles
- Beta-Blockers Reduce CV Mortality in Heart Failure With Preserved Ejection Fraction
- Timing of BP Measurements in Orthostatic Hypotension Linked to Adverse Effects
- Hypertension, Diabetes in Midlife Increase Risk of Dementia
- Reduced GFR Associated With Increased Atrial Fibrillation Risk
- Biomarker-Based Model Predicts Mortalty in Coronary Heart Disease
- Assessing Chest Pain in ER With Short-term Risk Stratification Tool
- Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives
- Shortness of Breath and Palpitations After a Funeral: Depression or Something Worse?
- Newly Diagnosed Atrial Fibrillation Benefits From Cardiology Care vs Primary Care
- Noncalcified, High-Risk Coronary Plaque Burden Increased With Psoriasis
- Case Study: Cardiac Manifestations of Rheumatoid Arthritis
- Preventing Venous Thromboembolism After Hip, Knee Arthoplasty: Comparing Anticoagulant Efficacy
- Patients Report Breakdowns in Hospital Care
- Evolocumab Added to Statin Therapy Does Not Affect Cognition
- Risk Stratification Using Platelet Aggregation in Stable CAD